Ignite Creation Date:
2024-05-05 @ 9:15 PM
Last Modification Date:
2024-10-26 @ 10:01 AM
Study NCT ID:
NCT00840931
Status:
COMPLETED
Last Update Posted:
2019-12-11
First Post:
2009-02-04
Brief Title:
Immunotherapy Using Lenalidomide Bystander Vaccine in High Risk Myelodysplastic Syndrome MDS
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute